Estrogen Replacement Therapy Market Share

North America industry is poised to dominate majority revenue share by 2037, driven by rising number of older women undergoing the menopause, which is increasing the demand for estrogen therapy in order to provide comfort and make daily life easier. The market in Europe is projected to hold a significant share in the market as well owing to advancements in technology in the healthcare industry which is resulting in development of new and improved estrogen replacement therapies with lesser side effects.